| Ident. | Authors (with country if any) | Title |
|---|
| 000013 (2013) |
Micha Levi [États-Unis] ; Susan Grange [États-Unis] ; Nicolas Frey [Suisse] | Exposure‐Exposure Relationship of Tocilizumab, an Anti–IL‐6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis |
| 000021 (2010) |
Nicolas Frey [Suisse] ; Susan Grange [Suisse] ; Thasia Woodworth [Royaume-Uni] | Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis |
| 000022 (2011) |
Leonid Gibiansky [États-Unis] ; Nicolas Frey [États-Unis] | Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach |
| 000051 (2008) |
Atsushi Taga [Japon] ; Soichiro Kita ; Kaori Nishiura [Japon] ; Tomonori Hayashi [Japon] ; Mitsuhiro Kinoshita ; Atsushi Sato [Japon] ; Kentaro Suzuki [Japon] ; Shuji Kodama [Japon] ; Kazuaki Kakehi | Analysis of an antibody pharmaceutical, tocilizumab, by capillary electrophoresis using a carboxylated capillary |
| 000088 (2011) |
Emily Beth Devine [États-Unis] ; Rafael Alfonso-Cristancho [États-Unis] ; Sean D. Sullivan [États-Unis] | Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach |
| 000145 (2012) |
I. Demin [Suisse] ; B. Hamrén [Suisse] ; O. Luttringer [Suisse] ; G. Pillai [Suisse] ; T. Jung [Suisse] | Longitudinal Model‐Based Meta‐Analysis in Rheumatoid Arthritis: An Application Toward Model‐Based Drug Development |
| 000173 (2013) |
Nam Trung Nguyen [Japon, Viêt Nam] ; Taisuke Nakahama [Japon] ; Tadamitsu Kishimoto [Japon] | Aryl hydrocarbon receptor and experimental autoimmune arthritis |
| 000179 (2009) |
Masahiko Mihara [Japon] ; Yoshiyuki Ohsugi [Japon] ; Tadamitsu Kishimoto | Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody |
| 000187 (2016) |
Yehong Wang [États-Unis] ; Rui Zhu [États-Unis] ; Jim Xiao [États-Unis] ; John C. Davis Jr [États-Unis] ; Jaap W. Mandema [États-Unis] ; Jin Y. Jin [États-Unis] ; Meina T. Tang [États-Unis] | Short‐Term Efficacy Reliably Predicts Long‐Term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model‐Based Meta‐Analysis |
| 000262 (2016) |
Peter Birner [Autriche] ; Susanne Heider [Autriche] ; Peter Petzelbauer [Autriche] ; Peter Wolf [Autriche] ; Christoph Kornauth [Autriche] ; Madeleine Kuroll [Autriche] ; Olaf Merkel [Autriche] ; Günter Steiner [Japon] ; Tadamitsu Kishimoto [Japon] ; Stefan Rose-John [Allemagne] ; Afschin Soleiman [Autriche] ; Richard Moriggl [Autriche] ; Lukas Kenner [Autriche] | Interleukin‐6 receptor alpha blockade improves skin lesions in a murine model of systemic lupus erythematosus |
| 000304 (2013) |
Tomokazu Nagao ; Reina Kusunoki ; Chiaki Iwamura ; Shigeto Kobayashi ; Wako Yumura ; Yosuke Kameoka [Japon] ; Toshinori Nakayama ; Kazuo Suzuki [Japon] | Correlation of interleukin‐6 and monocyte chemotactic protein‐1 concentrations with crescent formation and myeloperoxidase‐specific anti‐neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti‐interleukin‐6 receptor antibody or mizoribine |
| 000326 (2015) |
Takeshi Sainoh [Japon] ; Sumihisa Orita [Japon] ; Masayuki Miyagi [Japon] ; Yoshihiro Sakuma [Japon] ; Kazuyo Yamauchi [Japon] ; Miyako Suzuki [Japon] ; Go Kubota [Japon] ; Yasuhiro Oikawa [Japon] ; Kazuhide Inage [Japon] ; Jun Sato [Japon] ; Kazuki Fujimoto [Japon] ; Yasuhiro Shiga [Japon] ; Gen Inoue [Japon] ; Yasuchika Aoki [Japon] ; Kazuhisa Takahashi [Japon] ; Seiji Ohtori [Japon] | Interleukin‐6 and interleukin‐6 receptor expression, localization, and involvement in pain‐sensing neuron activation in a mouse intervertebral disc injury model |
| 000465 (2012) |
Yiping Hu [République populaire de Chine] ; Wenxiang Cheng [République populaire de Chine] ; Wenhong Cai [République populaire de Chine] ; Ye Yue [République populaire de Chine] ; Jinchao Li [République populaire de Chine] ; Peng Zhang [République populaire de Chine] | Advances in research on animal models of rheumatoid arthritis |
| 000814 (2013) |
Vladimir Ognenovski [États-Unis] ; Marija Arsovska-Nalbanti [Macédoine (pays)] ; Dragan Chichikj [Macédoine (pays)] ; Jordan Calovski [Macédoine (pays)] | Improving rheumatologic care and education in the Republic of Macedonia: model for rheumatologic education and care in a developing country—ILAR Initiative |
| 000874 (2012) |
Ti Wen [République populaire de Chine] ; Yangguang Li [République populaire de Chine] ; Meng Wu [République populaire de Chine] ; Xiaolin Sun [République populaire de Chine] ; Xiucong Bao [République populaire de Chine] ; Yuquan Lin [République populaire de Chine] ; Jianlei Hao [République populaire de Chine] ; Lin Han [République populaire de Chine] ; Guangchao Cao [République populaire de Chine] ; Ziwen Wang [République populaire de Chine] ; Yuxiu Liu [République populaire de Chine] ; Zhenzhou Wu [République populaire de Chine] ; Zhangyong Hong [République populaire de Chine] ; Puyue Wang [République populaire de Chine] ; Liqing Zhao [République populaire de Chine] ; Zhanguo Li [République populaire de Chine] ; Qingmin Wang [République populaire de Chine] ; Zhinan Yin [République populaire de Chine] | Therapeutic effects of a novel tylophorine analog, NK‐007, on collagen‐induced arthritis through suppressing tumor necrosis factor α production and Th17 cell differentiation |
| 000885 (2013) |
C. Gibbons ; A. Diamantopoulos [Royaume-Uni] ; H. Pang ; C. Huertas ; F. Dejonckheere [Suisse] | FRI0414 Tocilizumab in methotrexate-intolerant or contraindicated patients – a cost-utility model for scotland |
| 000925 (2012) |
P. A. Laires [Portugal] ; F. Exposto [Portugal] ; R. Mesquita [Portugal] ; A. P. Martins [Portugal] ; L. Cunha-Miranda [Portugal] ; J. E. Fonseca [Portugal] | Patients’ access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries |
| 000A15 (2013) |
S. Liu [Canada] ; A. Leask [Canada] | OP0155 A Novel Model of Systemic Sclerosis?: Loss of PTEN in Fibroblasts Results in Lung Fibrosis in A CCN2/CTGF-Dependent Fashion |
| 000A44 (2012) |
Huiqiang Chen [République populaire de Chine] ; Bin Yu [République populaire de Chine] ; Changhuai Lu [République populaire de Chine] ; Qingrong Lin [République populaire de Chine] | The effect of intra-articular injection of different concentrations of ozone on the level of TNF-α, TNF-R1, and TNF-R2 in rats with rheumatoid arthritis |
| 000B16 (2012) |
D R Mould [États-Unis, Niger] | Model‐Based Meta‐Analysis: An Important Tool for Making Quantitative Decisions During Drug Development |
| 000B71 (2013) |
L.-H. Wang ; Y. Xue ; X. Liu ; F. Luo ; L. Kelly ; T. Huang ; D. Valenzuela ; N. Papdopoulos ; N. Graham [États-Unis] ; A. Murphy | FRI0020 Preclinical development of sarilumab, the first fully human monoclonal antibody (MAB) against IL-6r alpha: utilization and value of double humanized animal model |
